Hypertrophic Obstructive Cardiomyopathy: Clinical Trials

2 unknown. 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	2	Unknown 2

Follow Hypertrophic Obstructive Cardiomyopathy: new trials by email Literature Review of Hypertrophic Obstructive Cardiomyopathy trials Research Report on Hypertrophic Obstructive Cardiomyopathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test Pre and post-CPB Drug: Dobutamine Hydrochloride, Post-CPB Drug: Dobutamine Hydrochloride - Hypertrophic Obstructive Cardiomyopathy	Phase 4	Unknown	University Health Network, Toronto	60	2023-03-01	2022-11-08
Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy Esmolol, Placebo - Hypertrophic Obstructive Cardiomyopathy	Phase 4	Unknown	Meshalkin Research Institute of Pathology of Circulation	80	2021-10-06	2021-10-11

Narrower conditions

Cardiomyopathy, Hypertrophic (2)

Broader conditions

Aortic Stenosis, Subvalvular (2)  ·  Aortic Valve Disease (2)  ·  Aortic Valve Stenosis (2)  ·  Cardiomyopathies (2)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Heart Valve Diseases (2)

Interventions

Lead (1)  ·  esmolol (1)

Sponsors

Meshalkin Research Institute of Pathology of Circulation (1)  ·  University Health Network, Toronto (1)

Countries

Russia (1)

Top investigators

Azad Mashari, MD (1)  ·  Jacobo Moreno Garijo, MD (1)